Macquarie Group LTD Organogenesis Holdings Inc. Transaction History

Macquarie Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.14 - $6.43 $194 - $398	-62 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.47 - $9.57 $14.6 Million - $21.7 Million	-2,262,990 Reduced 100.0%	62 $0
Q4 2021 Feb 11, 2022	BUY	$9.02 - $13.5 $9.23 Million - $13.8 Million	1,023,794 Added 82.61%	2,263,052 $20.9 Million
Q3 2021 Nov 12, 2021	BUY	$13.71 - $17.18 $17 Million - $21.3 Million	1,239,258 New	1,239,258 $17.6 Million

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.